Worries about stunted growth in FEMSA's OXXO convenience store chain were eased. Click here to read why I maintain FMX stock ...

In a report released on February 28, Jason Zemansky from Bank of America Securities maintained a Buy rating on Rocket Pharmaceuticals (RCKT – ...

Top-rated analyst David Williams from Benchmark Co. has maintained his Buy rating on the U.S.-based quantum computing company ...

Shoals Technologies Group, Inc. is a leader in solar EBOS, poised for growth with innovation, strong financials, and market ...

We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

Archer Aviation (NYSE:ACHR – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research note issued on Friday,Benzinga reports. They presently have a $12.50 target price on ...

What should go on your watchlist? Is a buy rating enough to make a move on the stock market today? Are you buying up assets that have room to grow, or are you swing trading with pricier stocks?

Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

Rated "hold" by Argus with limited 12-month upside. Argus maintains a five-year "buy" rating with no price target. Vertex Pharmaceuticals specializes in developing therapies to treat cystic ...

The entire IT pack is under pressure today and Coforge share price is down 3%. In fact the stock is down 12% over 1 month and slumped 25% so far in 2025. Despite that Jefferies has reiterated its Buy ...

Apple stock returned more than 30% in 2024, but Jefferies analyst Edison Lee is concerned that "weak demand for the iPhone has materialized," while other products, such as the iPad and MacBook ...